Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionHighTower Advisors, LLC
Latest Disclosed Ownership9,769 shares
Latest Disclosed Value $ 212,573
HighTower Advisors, LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On May 5, 2026 - HighTower Advisors, LLC filed a 13F-HR form disclosing ownership of 9,769 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $212,573 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 0 shares of Sarepta Therapeutics, Inc..

HighTower Advisors, LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 9,769 9,769 213 0.0002
2026-02-06 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -29,977 -100.00 0 -100.00
2025-11-07 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 29,977 -12,347 -29.17 578 -20.19 0.0007
2025-08-11 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 42,324 4,727 12.57 724 -69.86 0.0009
2025-05-13 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 37,597 823 2.24 2,399 -46.34 0.0033
2025-02-07 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 36,774 -2,559 -6.51 4,471 -8.19 0.0061
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 39,333 -10,327 -20.80 4,870 -38.01 0.0070
2024-08-13 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 49,660 14,366 40.70 7,856 72.36 0.0121
2024-05-06 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 35,294 -777 -2.15 4,558 31.13 0.0074
2024-02-12 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 36,071 4,122 12.90 3,476 -9.97 0.0058
2023-11-08 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 31,949 -31 -0.10 3,861 5.55 0.0073
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 31,980 -5,557 -14.80 3,658 -29.41 0.0072
2023-05-12 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 37,537 -632 -1.66 5,182 4.90 0.0113
2023-02-09 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 38,169 -263 -0.68 4,940 16.18 0.0113
2022-11-09 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 38,432 -12,433 -24.44 4,252 12.04 0.0114
2022-08-10 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 50,865 11,880 30.47 3,795 24.18 0.0098
2022-05-12 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 38,985 -78 -0.20 3,056 -13.40 0.0068
2022-02-10 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 39,063 -1,364 -3.37 3,529 -5.41 0.0077
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 40,427 41 0.10 3,731 18.56 0.0100
2021-08-06 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 40,386 6,577 19.45 3,147 24.98 0.0091
2021-05-10 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 33,809 2,270 7.20 2,518 -53.21 0.0079
2021-02-10 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 31,539 3,271 11.57 5,382 35.60 0.0224
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 28,268 -562 -1.95 3,969 -13.98 0.0192
2020-08-10 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 28,830 -1,193 -3.97 4,614 57.15 0.0252
2020-05-21 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 30,023 -283 -0.93 2,936 -24.91 0.0190
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 30,306 -1,672 -5.23 3,910 61.50 0.0231
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 31,978 -2,956 -8.46 2,421 -54.44 0.0132
2019-08-13 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 34,934 -5,659 -13.94 5,314 9.70 0.0316
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 40,593 -3,721 -8.40 4,844 0.23 0.0324
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 44,314 -4,210 -8.68 4,833 -38.28 0.0371
2018-11-09 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 48,524 -552 -1.12 7,830 20.65 0.0564
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 49,076 -9,884 -16.76 6,490 48.58 0.0508
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 58,960 -9,558 -13.95 4,368 14.23 0.0366
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 68,518 -1,078 -1.55 3,824 20.78 0.0314
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 69,596 16,119 30.14 3,166 75.89 0.0270
2017-09-22 2017-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 53,477 6,902 14.82 1,800 30.34 0.0161
2017-08-14 2017-06-30 13F SAREPTA THERAPEUTICS COM 803607100 53,477 6,902 1,800
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 46,575 5,225 12.64 1,381 21.78 0.0132
2017-02-10 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 41,350 10,540 34.21 1,134 -40.03 0.0123
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 30,810 -8,147 -20.91 1,891 153.15 0.0219
2016-08-11 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 38,957 21,303 120.67 747 116.52 0.0095
2016-05-16 2016-03-31 13F SAREPTA THERAPEUTICS COM 803607100 17,654 17,654 0.00 345 0.0011
2016-05-18 2015-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 0 0 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-07 2025-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2025-08-11 2025-06-30 13F SAREPTA THERAPEUTICS COM Call 500 0.00 0 -100.00 n/a n/a n/a
2025-05-13 2025-03-31 13F SAREPTA THERAPEUTICS COM Call 500 1 n/a n/a n/a
2021-02-10 2020-12-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM Call 200 0.00 2 0.00 n/a n/a n/a
2020-08-10 2020-06-30 13F SAREPTA THERAPEUTICS COM Call 200 -33.33 2 -66.67 n/a n/a n/a
2020-05-21 2020-03-31 13F SAREPTA THERAPEUTICS COM Call 300 -50.00 6 -40.00 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM Call 600 -33.33 10 400.00 n/a n/a n/a
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM Call 900 350.00 2 -60.00 n/a n/a n/a
2019-08-13 2019-06-30 13F SAREPTA THERAPEUTICS COM Call 200 0.00 5 400.00 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM Call 200 1 n/a n/a n/a
2018-11-09 2018-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM Call 100 1 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM Call 200 2 n/a n/a n/a
2017-09-22 2017-06-30 13F/A SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM Call 500 1 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-11-09 2022-09-30 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-10 2022-06-30 13F SAREPTA THERAPEUTICS COM Put 7,000 42 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM Put 200 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.